Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2015

Feb 26, 2015

29821_dirs_2015-02-26_890840a9-1acc-417c-ac82-2847f390a24e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2015-02-24

Reporting Person: Prange Karen (SVP&Pres, Uro & Women's Health)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-24 Common Stock M 2102.0000 $0.0000 Acquired 19532.0000 Direct
2015-02-24 Common Stock F 795.0000 $16.6200 Disposed 18737.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-24 Deferred Stock Units $ M 2102.0000 Disposed 2019-02-24 Common Stock (2102.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1000.0000 Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.